Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| DNLI |
| Denali Therapeutics Inc. |
| AGRANT◆ |
| 236,880 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jan 3 | DNLI | Denali Therapeutics Inc. | AGRANT | 78,960 | — | — | +31.2% | Open the original filing on SEC.gov |
| Sep 3, 2025 | DNLI | Denali Therapeutics Inc. | GGIFT | 50,000 | — | — | -2.3% | Open the original filing on SEC.gov |
| Jul 9, 2025 | DNLI | Denali Therapeutics Inc. | MEXER◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 9, 2025 | DNLI | Denali Therapeutics Inc. | MEXER◷◆ | 455,282 | — | — | — | Open the original filing on SEC.gov |
| Jul 9, 2025 | DNLI | Denali Therapeutics Inc. | SSELL◷ | 495,282 | $15.00 | $7.4M | -66.2% | Open the original filing on SEC.gov |
| Jul 9, 2025 | DNLI | Denali Therapeutics Inc. | MEXER◷ | 40,000 | $5.28 | $211.2K | +5.7% | Open the original filing on SEC.gov |
| Jul 9, 2025 | DNLI | Denali Therapeutics Inc. | MEXER◷ | 455,282 | $0.68 | $309.6K | +179.9% | Open the original filing on SEC.gov |